Ultrasonic Neuromodulation of Cingulate Cortex for Fibromyalgia

Recruiting N/A Interventional Study
Fibromyalgia
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
22 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
180 (estimated)
Sponsor
SPIRE Therapeutics Inc. · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The goal of this clinical trial is to evaluate a new noninvasive brain stimulation intervention for fibromyalgia and to determine its effectiveness in reducing pain. Participants will receive four treatments over the course of one month and will complete surveys at multiple time points throughout the 16-week study.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Willing and able to provide informed consent. 2. Age ≥ 22 years. 3. Meets 2016 American College of Rheumatology criteria for fibromyalgia: 1. Generalized pain, defined as pain in at least 4 of 5 regions, is present, AND 2. Widespread pain index (WPI) ≥ 7 and symptom se…
Contacts

Akiko Okifuji, PhD

801-585-7690

Akiko.Okifuji@hsc.utah.edu

CONTACT